From the FDA: Manufacturing deficiencies with Abbokinase prompt FDA letter to Abbot Laboratories | The Journal of the American Osteopathic Association

Free

News | August 1999

From the FDA: Manufacturing deficiencies with Abbokinase prompt FDA letter to Abbot Laboratories

Article Information

The Journal of the American Osteopathic Association, August 1999, Vol. 99, 397. doi:10.7556/jaoa.1999.99.8.396g

- Email
- Facebook
- Linkedin
- Twitter
- CiteULike
- Get Permissions
- Get Citation
  Citation
  
  From the FDA: Manufacturing deficiencies with Abbokinase prompt FDA letter to Abbot Laboratories. J Am Osteopath Assoc 1999;99(8):397. doi: 10.7556/jaoa.1999.99.8.396g.
  
  Download citation file:
  - Ris (Zotero)
  - EndNote
  - BibTex
  - Medlars
  - ProCite
  - RefWorks
  - Reference Manager
  © 2019
  ×
- Alerts
  
  User Alerts
  
  You are adding an alert for:
  
  From the FDA: Manufacturing deficiencies with Abbokinase prompt FDA letter to Abbot Laboratories
  
  You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
  
  The alert will be sent to:
  
  Confirm
  
  ×
  
  This feature is available to Subscribers Only
  Sign In or Subscribe ×